UBS crosses 3 percent threshold. Azelis stock trades 1.84 percent below its 52-week high

Published on 10/19/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue reached EUR 2.2 billion, up 3.20 percent. Azelis stock costs EUR 13.32 on October 19, 2026 below its EUR 13.57 high.

Ownership and earnings calendar

UBS held 3.02 percent of voting rights on October 8, 2026.
First-half revenue reached EUR 2.2 billion, up 3.20 percent year over year.
Azelis stock was trading at EUR 13.32 at 10:00 a.m. CEST at Lang & Schwarz on October 19, 2026.
Azelis is scheduled to report third-quarter results on October 22, 2026.

Azelis, BE0974400328, Illustration mit AI erstellt.

Azelis (ISIN BE0974400328) was trading at EUR 13.32 at Lang & Schwarz on October 19, 2026 at 10:00 a.m. CEST, 1.84 percent below its 52-week high of EUR 13.57. The company disclosed that UBS crossed above and then below the 3 percent voting-rights threshold in October, according to Business Wire on October 13, 2026.

UBS position changed within days

UBS reported holdings representing 3.02 percent of Azelis voting rights after transactions on October 8, 2026. The position included 1,090,312 voting shares, equal to 0.45 percent, and 6,278,198 equivalent financial instruments, equal to 2.57 percent, according to Business Wire.

UBS then crossed below the 3 percent threshold after a disposal on October 9, 2026. Azelis did not disclose further details on the remaining direct and indirect holdings in that notification, the same release said.

What does the earnings setup show?

Azelis generated EUR 2.2 billion of revenue in the first half of 2026, an increase of 3.20 percent from the prior year. Adjusted EBITDA reached EUR 233 million, up 2.60 percent, while the adjusted EBITDA margin was 10.70 percent, according to the Yahoo Finance transcript.

The regional mix was uneven. First-half revenue in Asia Pacific rose 8.20 percent to EUR 428 million, while EMEA revenue increased 1.70 percent to EUR 990 million. The figures show why the October results will be important for assessing whether the recovery is broadening beyond the strongest region.

Three dated steps for Azelis

On July 30, 2026, Azelis reported first-half revenue of EUR 2.2 billion and adjusted EBITDA of EUR 233 million. On October 8, 2026, UBS reported 3.02 percent of voting rights, according to Business Wire.

On October 13, 2026, Azelis disclosed that UBS had crossed back below 3 percent. The ownership change is separate from the operating recovery described in the first-half figures.

Two dates shape the calendar

Azelis is scheduled to report third-quarter 2026 results on October 22, 2026, with Jefferies expecting EBITA of EUR 108 million, 10 percent above the prior-year figure but 5 percent below consensus of EUR 113.4 million, according to MarketScreener on October 12, 2026.

The company is also scheduled to report fiscal-year 2026 results on February 18, 2027, according to Simply Wall St.

Stock remains below yearly high

The EUR 13.32 indication is EUR 0.25 below the 52-week high of EUR 13.57 and above the 52-week low of EUR 6.88. Azelis has a market capitalization of EUR 3.2 billion as of October 19, 2026, while the primary listing is on Euronext Brussels.

Azelis was trading at EUR 13.32 at Lang & Schwarz on October 19, 2026 at 10:00 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Azelis stock.